PANoptosis in diabetic retinopathy: immunological insights into mechanisms and translational therapies - Takeaways - MDSpire

PANoptosis in diabetic retinopathy: immunological insights into mechanisms and translational therapies

  • By

  • Lingli Ma

  • Ning Hou

  • Xiaoyu Zhao

  • Zimeng Li

  • Qing Liu

  • Jianyu Zhao

  • Qing Wang

  • June 19, 2026

  • 0 min

Share

  • 1

    Diabetic retinopathy (DR) is a major cause of blindness, driven by hyperglycemia-induced neurovascular damage and characterized by retinal neurodegeneration.

  • 2

    PANoptosis, an inflammatory programmed cell death modality, plays a role in the progression of diabetic retinal damage.

  • 3

    Research on PANoptosis in DR highlights gaps in understanding its mechanisms, including PANoptosome signaling and the role of non-coding RNAs.

  • 4

    Current therapeutic strategies should prioritize biomarker-guided, localized delivery and cell-type-specific modulation of PANoptosis-related pathways.

  • 5

    The review emphasizes the need for mechanistic verification and well-designed clinical trials to advance targeted interventions in DR.

Original Source(s)

PANoptosis in diabetic retinopathy: immunological insights into mechanisms and translational therapies

  • by Lingli Ma, Ning Hou, Xiaoyu Zhao, Zimeng Li, Qing Liu, Jianyu Zhao, Qing Wang

  • June 19, 2026

Related Content

The Retina: A Window on Neurodegeneration

New evidence links Chlamydia pneumoniae to retinal inflammation patterns associated with neurodegeneration

  • March 9, 2026

  • 7 min
Investigation of Ultrawidefield OCTA to Assess the Effects of Posterior Precorical Vitreous Pocket on Retinal and Choroidal Structure and Blood Flow

Medical Oddities: Pig Semen, Meet Eye Drops

Evolution, sex, soil, and diets—this lineup covers a little bit of everything.